Hematologic disorders associated with COVID-19: a review Mandeep Singh RahiVishal JindalIshmael Jaiyesimi Review Article 07 January 2021 Pages: 309 - 320
Prophylaxis, diagnosis and therapy of infections in patients undergoing high-dose chemotherapy and autologous haematopoietic stem cell transplantation. 2020 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO) Maximilian ChristopeitMartin Schmidt-HieberGeorg Maschmeyer Review Article Open access 20 October 2020 Pages: 321 - 336
Catching the clinical and biological diversity for an appropriate therapeutic approach in systemic mastocytosis Francesco Mannelli Review Article 06 November 2020 Pages: 337 - 344
Clinical association between thyroid disease and immune thrombocytopenia Shoko ItoShin-ichiro FujiwaraYoshinobu Kanda Original Article 09 November 2020 Pages: 345 - 352
Congenital dyserythropoietic anemia types Ib, II, and III: novel variants in the CDIN1 gene and functional study of a novel variant in the KIF23 gene Manuel MéndezMaría Isabel Moreno-CarraleroMaría José Morán-Jiménez Original Article 07 November 2020 Pages: 353 - 364
Krüppel-like factor 1 (KLF1) gene single nucleotide polymorphisms in sickle cell disease and its association with disease-related morbidities Ravindra KumarRajiv YadavShanmugam Rajasubramaniam Original Article 03 January 2021 Pages: 365 - 373
ADAMTS-13–VWF axis in sickle cell disease patients Valéria Sutana LadeiraAmanda Rodrigues BarbosaDanyelle Romana Alves Rios Original Article 06 January 2021 Pages: 375 - 382
COVID-19 in cancer patients: clinical characteristics and outcome—an analysis of the LEOSS registry Maria Madeleine RüthrichC. Giessen-Jungon behalf of the LEOSS Study Group Original Article Open access 07 November 2020 Pages: 383 - 393
Analysis of blood stream infections, antibiograms and clinical outcomes in haematological patients with febrile neutropenia: data from a tertiary care haematology institute in India Shouriyo GhoshMandira ChakrabortyMaitreyee Bhattacharyya Original Article 02 November 2020 Pages: 395 - 403
The role of novel agents for consolidation after autologous transplantation in newly diagnosed multiple myeloma: a systematic review Nico GagelmannNicolaus Kröger Original Article 29 October 2020 Pages: 405 - 419
A new parameter in multiple myeloma: CYP3A4*1B single nucleotide polymorphism Istemi SerinSacide PehlivanMustafa Pehlivan Original Article 10 November 2020 Pages: 421 - 427
Carfilzomib, lenalidomide, and dexamethasone in relapsed/refractory multiple myeloma patients: the real-life experience of Rete Ematologica Pugliese (REP) Anna MeleEleonora PreteVincenzo Pavone Original Article 07 November 2020 Pages: 429 - 436
A longitudinal analysis of chromosomal abnormalities in disease progression from MGUS/SMM to newly diagnosed and relapsed multiple myeloma Stefania OlivaLorenzo De PaoliPaola Omedé Original Article 03 January 2021 Pages: 437 - 443
Prognostic value of 25-hydroxy vitamin D in extranodal NK/T cell lymphoma Jin MaoHua YinWei Xu Original Article 02 November 2020 Pages: 445 - 453
Analysis of the impact of adherence to guidelines and expert advice in patients with myelodysplastic syndromes A. KasprzakK. NachtkampU. Germing Original Article Open access 07 November 2020 Pages: 455 - 463
Prognostic value of ASXL1 mutations in patients with primary myelofibrosis and its relationship with clinical features: a meta-analysis Ziqing WangWeiyi LiuXiaomei Hu Original Article Open access 02 January 2021 Pages: 465 - 479
Mortality rate in patients with chronic myeloid leukemia in chronic phase treated with frontline second generation tyrosine kinase inhibitors: a retrospective analysis by the monitoring registries of the Italian Medicines Agency (AIFA) Massimo BrecciaSimone Celanton behalf of AIFA Monitoring Registries Group Original Article 07 January 2021 Pages: 481 - 485
Distinct clinical and biological characteristics of acute myeloid leukemia with higher expression of long noncoding RNA KIAA0125 Yu-Hung WangChien-Chin LinHwei-Fang Tien Original Article Open access 23 November 2020 Pages: 487 - 498
Newly diagnosed isolated myeloid sarcoma–paired NGS panel analysis of extramedullary tumor and bone marrow Nils W. EngelJochim ReinertWalter Fiedler Original Article Open access 27 October 2020 Pages: 499 - 503
Prognosis and risk factors for central nervous system relapse after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia Qi ChenXiao-Lu ZhuXiao-Hui Zhang Original Article 02 January 2021 Pages: 505 - 516
Preemptive low-dose interleukin-2 or DLI for late-onset minimal residual disease in acute leukemia or myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation Xiao-Lin YuanYa-Min TanYi Luo Original Article 31 October 2020 Pages: 517 - 527
Post-transplant cyclophosphamide versus antithymocyte globulin in allogeneic hematopoietic cell transplantation: a meta-analysis Feiqiong GaoJiawei ZhangYang Xu Original Article 08 January 2021 Pages: 529 - 540
Post-transplant cyclophosphamide for GVHD prophylaxis compared to ATG-based prophylaxis in unrelated donor transplantation Rebeca BailénMi Kwonon behalf of Grupo Español de Trasplante Hematopoyético y Terapia Celular (GETH) Original Article 02 November 2020 Pages: 541 - 553
Allogeneic hematopoietic stem cell transplantation for intermediate-risk acute myeloid leukemia in the first remission: outcomes using haploidentical donors are similar to those using matched siblings Yan-Ru MaLan-Ping XuYu Wang Original Article 07 January 2021 Pages: 555 - 562
Comparison of the efficiency, safety, and survival outcomes in two stem cell mobilization regimens with cyclophosphamide plus G-CSF or G-CSF alone in multiple myeloma: a meta-analysis Liwen WangHongxian XiangJing Liu Original Article Open access 06 January 2021 Pages: 563 - 573
Correction to: Comparison of the efficiency, safety, and survival outcomes in two stem cell mobilization regimens with cyclophosphamide plus G-CSF or G-CSF alone in multiple myeloma: a meta-analysis Liwen WangHongxian XiangJing Liu Correction 18 January 2021 Pages: 575 - 575
Primary pulmonary diffuse large B cell lymphoma presenting as bulky bilateral lung tumors Kyosuke SaekiMakoto NakamuraKensuke Kojima Letter to the Editor 16 May 2020 Pages: 577 - 578
Coincidence of autoimmune hemolytic anemia and pure red cell aplasia in a patient with CLL Michael J. HochmanDaniel B. Martin Letter to the Editor 16 June 2020 Pages: 579 - 580
Durable remission with ruxolitinib in a chronic neutrophilic leukemia patient harboring a truncation and membrane proximal CSF3R compound mutation Anna HinzeJenny RinkeThomas Ernst Letter to the Editor Open access 23 June 2020 Pages: 581 - 584
Prenatal diagnosis of familial hemophagocytic lymphohistiocytosis: morphological findings in the product of conception Magda ZanelliMaurizio ZizzoStefano Ascani Letter to the Editor 04 June 2020 Pages: 585 - 586
Sequential therapy with inotuzumab ozogamicin, CD19 CAR T cells, and blinatumomab in an elderly patient with relapsed acute lymphoblastic leukemia Ramona WullenkordChristian ReichertsMatthias Stelljes Letter to the Editor Open access 22 August 2020 Pages: 587 - 589
Remarkable response to roxadustat in a case of anti-erythropoietin antibody-mediated pure red cell aplasia Ke WanYafei YinJianzhao Cheng Letter to the Editor 17 September 2020 Pages: 591 - 593
Risk of tumor lysis syndrome in patients with acute myeloid leukemia treated with venetoclax-containing regimens without dose ramp-up Rabia ShahswarGernot BeutelMichael Heuser Letter to the Editor Open access 23 July 2020 Pages: 595 - 599
